Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy

Max Kam-Kwan Chan; Emily Lok-Yiu  Chan; Zoey Zeyuan  Ji; Siu Wing Alex Chan; Chunjie Li; Kam Tong Leung; Ka Fai To; Ming Kuen Patrick Tang

doi:10.37349/etat.2023.00137

Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy

Max Kam-Kwan Chan, Emily Lok-Yiu Chan, Zoey Zeyuan Ji, Siu Wing Alex Chan, Chunjie Li, Kam Tong Leung, Ka Fai To, Ming Kuen Patrick Tang

Department of Applied Social Sciences

Research output: Journal article publication › Journal article › Academic research › peer-review

18 Citations (Scopus)

Original language	English
Pages (from-to)	316-343
Journal	Exploration of Targeted Anti-tumor Therapy
Volume	4
Issue number	2
DOIs	https://doi.org/10.37349/etat.2023.00137
Publication status	Published - 28 Apr 2023

More information

10.37349/etat.2023.00137

Cite this

@article{da7f51ed995544d7ba6b6e8b85bd97b1,

title = "Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy",

author = "Chan, {Max Kam-Kwan} and Chan, {Emily Lok-Yiu} and Ji, {Zoey Zeyuan} and Chan, {Siu Wing Alex} and Chunjie Li and Leung, {Kam Tong} and To, {Ka Fai} and Tang, {Ming Kuen Patrick}",

year = "2023",

month = apr,

day = "28",

doi = "10.37349/etat.2023.00137",

language = "English",

volume = "4",

pages = "316--343",

journal = "Exploration of Targeted Anti-tumor Therapy",

issn = "2692-3114",

publisher = "Open Exploration Publishing Inc",

number = "2",

}

TY - JOUR

T1 - Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy

AU - Chan, Max Kam-Kwan

AU - Chan, Emily Lok-Yiu

AU - Ji, Zoey Zeyuan

AU - Chan, Siu Wing Alex

AU - Li, Chunjie

AU - Leung, Kam Tong

AU - To, Ka Fai

AU - Tang, Ming Kuen Patrick

PY - 2023/4/28

Y1 - 2023/4/28

U2 - 10.37349/etat.2023.00137

DO - 10.37349/etat.2023.00137

M3 - Journal article

SN - 2692-3114

VL - 4

SP - 316

EP - 343

JO - Exploration of Targeted Anti-tumor Therapy

JF - Exploration of Targeted Anti-tumor Therapy

IS - 2

ER -